Jay Alan Martin
|
(415) 519-1929 |
·
Medical,
scientific, and technical writing
·
Technical
editing
·
Web
content writing
·
Hands-on
biomedical research
·
Experience
in academic, corporate, and non-profit environments
·
Strong
familiarity with drug-development process
·
Excellent
project management skills
Applied
Biosystems,
Senior
Technical Writer, Technical Editor (July 2007 – present)
·
Write
and manage information as Project Team Leader for Information Development on
the SOLiD™ System team. SOLiD™ is the next-generation technology for
high-throughput sequencing of the human genome.
·
Edit
in-house documents for clarity and coherence of technical information.
Scleroderma
Research Foundation,
Director of Medical Information (2005 – 2007)
·
Authored
the Foundation website’s scientific and medical content, in consultation with
recognized medical experts in the area of scleroderma research.
·
Rewrote
the Foundation handbook to make it more accessible to scleroderma patients.
·
Developed
and introduced phone scripts to improve the consistency and effectiveness of
the Foundation’s message.
·
Established
the Foundation’s first literature database with over 1200 references.
·
Created
the strategy to upgrade the organization, usability and presentation of the
Foundation website to meet the needs of patients and physicians.
Elsevier MDL, Inc.,
Senior Technical
Communicator (2001 – 2005)
·
Wrote
and edited software manuals for MDL’s Biological-Assay software. Worked with
in-house subject-matter experts to improve the scientific reference materials
and worked examples for the research-biologist audience for this software.
·
Worked
with subject-matter experts at remote offices to create new reference materials
and online help for MDL’s Drug-Safety Assessment software.
·
Served
as Project-Team Representative for several MDL products, working with team
members to ensure accurate, comprehensive, and relevant chemistry- and
biology-related reference materials and examples.
Institute for OneWorld Health,
Medical Writer (2002 – 2004; pro bono)
·
Contributed
summary of aminoglycoside-drug interactions in NDA that was submitted to the
Indian regulatory agency for eventual approval of paromomycin for treatment of
visceral leischmaniasas.
·
Summarized
clinical data of some of the Institute’s lead compounds for international drug
applications.
Genentech, Inc.,
GMP Technical Writer (1999
– 2001)
·
Wrote
validated procedures for Genentech’s first high-speed drug-packaging line using
the 21 CFR Part 11-compliant NovaManage, the electronic document-management and
auditing system.
·
Used
contextual inquiry methods, such as shadowing and interviewing operators, to
organize and write standard operating procedures conforming to GMP requirements
for next-generation packaging equipment.
·
Received
seven “Recognition and Thanks Awards” for excellent work performance.
Genentech, Inc.,
Senior Research
Associate
(1998 – 1999)
·
Analyzed
role of novel gene family implicated in colon cancer.
Chiron Corp. (now
Novartis Vaccines and Diagnostics, Inc.),
Specialist
II, Chiron Corporation, (1994 - 1998)
·
Examined
signaling mechanisms in animal development.
·
Coauthored
paper on initiation and cell cycle.
·
Contributed
toward award-winning design of
Staff Research Associate II-III (1990 – 1994)
·
Showed
that oncogene, Raf-1, interacts with scaffold protein 14-3-3 in vivo.
·
Certificate
in Technical Communication, UC Berkeley Ext., Dec, 2001.
·
M.S.,
Cellular Physiology,
Thesis:
The Role of Elongation Factor-2 Phosphorylation in Translational Regulation.
·
B.A.,
Chemistry,
Continuing Education
and Professional Development
·
Advanced
Editorial Workshop: Substantive Editing, Fall 2007
·
“Intermediate
Copyediting,”
·
“Photojournalism,”
·
“Introduction
to Clinical Data Management and Biostatistics,”
·
“Clinical
Trial Designs,” UC Berkeley Ext., November 2005.
·
“Writing
the Feature Story,” UC Berkeley Ext., June 2005.
·
“Data
Mining and Statistical Modeling with Applications,” UC Berkeley Ext., 2003.
·
“News
Writing,” UC
Published papers
Martin, J.,
Halenbeck, R, and J. Kaufmann. "The
Human Transcription
Factor hTAFII150 (CIF150) is Involved in the Transcriptional
Regulation of Cell Cycle Progression."
Molecular and Cellular
Biology19 (1999):5548-56.
Fantl, W.J., Muslin,
A.J., Kikuchi, A., Martin, J.A., MacNicol, A.M., Gross, R.W., and Williams,
L.T. "Activation of Raf-1 by 14-3-3
Proteins." Nature 371 (1994):612-614.
Schneider, A.,
Martin, J., and Agabian, N. "A Nuclear-Encoded tRNA
of Trypanosoma brucei is Imported
into Mitochondria." Molecular and Cellular Biology14 (1994):2317-2322.
Grueso-Salazar, E.F.,
Routbort, M.J., Martin, J.,
"Polyclonal IgM Anti-GM1 Ganglioside Antibody in Patients with
Motor Neuron Disease and Variants."
Annals of Neurology27
(1990):558-563.
References
are available upon request.
Writing samples and
references: available
upon request.